Insider Trading Summary for BioMarin Pharmaceutical Inc. (BMRN): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
26-May-22 8:45 PM View:	24-May-22 Grant 0	Heron Elaine J Director		BioMarin Pharmaceutical Inc. - BMRN	19% 72.09K to 85.57K	0	0	--	--	Show Txns Hide Txns

26-May-22 9:24 PM View:	24-May-22 Grant 0	Meier Richard A Director		BioMarin Pharmaceutical Inc. - BMRN	10% 99.39K to 108.99K	0	0	--	--	Show Txns Hide Txns

26-May-22 9:15 PM View:	24-May-22 Grant 0	Lawlis V Bryan Director		BioMarin Pharmaceutical Inc. - BMRN	21% 23.97K to 28.95K	0	0	--	--	Show Txns Hide Txns

18-Jan-23 9:41 PM View:	17-Jan-23 Option Sale ($1.12M)	Bienaime Jean Jacques Chief Executive Officer Director		BioMarin Pharmaceutical Inc. - BMRN	3% 551.32K to 567.96K	0	($489.38K) (1%)	--	$86.55 - $89.89	Show Txns Hide Txns

26-May-22 9:42 PM View:	24-May-22 Grant 0	Slamon Dennis Director		BioMarin Pharmaceutical Inc. - BMRN	(5%) 28.04K to 26.62K	0	($501.01K) (23%)	--	$78.33	Show Txns Hide Txns

26-May-22 9:32 PM View:	24-May-22 Grant 0	Pyott David E I Director		BioMarin Pharmaceutical Inc. - BMRN	14% 35.86K to 40.84K	0	0	--	--	Show Txns Hide Txns

27-Jan-23 9:35 PM View:	25-Jan-23 Option Sale ($5.67M)	Ajer Jeffrey Robert EVP, Chief Commercial Officer		BioMarin Pharmaceutical Inc. - BMRN	(26%) 55.85K to 41.09K	0	($1.26M) (28%)	--	$79.43 - $86.12	Show Txns Hide Txns

26-May-22 8:29 PM View:	24-May-22 Grant 0	Dere Willard H Director		BioMarin Pharmaceutical Inc. - BMRN	27% 18.41K to 23.39K	0	0	--	--	Show Txns Hide Txns

17-Mar-22 9:47 PM View:	16-Mar-22 Payment of Exercise ($182.35K)	Fuchs Henry J President, Worldwide R&D		BioMarin Pharmaceutical Inc. - BMRN	35% 106.48K to 143.75K	0	0	--	--	Show Txns Hide Txns

26-May-22 9:07 PM View:	24-May-22 Grant 0	Hombach Robert J. Director		BioMarin Pharmaceutical Inc. - BMRN	23% 21.33K to 26.31K	0	0	--	--	Show Txns Hide Txns

26-May-22 8:20 PM View:	24-May-22 Grant 0	Anderson Elizabeth M Director		BioMarin Pharmaceutical Inc. - BMRN	36% 13.91K to 18.89K	0	0	--	--	Show Txns Hide Txns

17-Jan-23 9:57 PM View:	13-Jan-23 Option Sale ($286.25K)	Mueller Brian EVP, Chief Financial Officer		BioMarin Pharmaceutical Inc. - BMRN	(10%) 30.78K to 27.75K	0	($656.66K) (24%)	--	$89.50	Show Txns Hide Txns

10-Aug-22 7:52 PM View:	08-Aug-22 Private Sale ($599.16K)	Guyer Charles Greg EVP, Chief Technical Officer		BioMarin Pharmaceutical Inc. - BMRN	1% 41.94K to 42.17K	0	0	--	--	Show Txns Hide Txns

26-May-22 8:57 PM View:	24-May-22 Grant 0	Ho Maykin Director		BioMarin Pharmaceutical Inc. - BMRN	67% 7.47K to 12.45K	0	0	--	--	Show Txns Hide Txns

02-Nov-22 6:42 PM View:	31-Oct-22 Market Purchase $314.47K	Alles Mark J Director		BioMarin Pharmaceutical Inc. - BMRN	374% 2.3K to 10.9K	$314.47K 158%	0	$86.75	--	Show Txns Hide Txns

11-Aug-22 9:01 PM View:	09-Aug-22 Sale ($354.09K)	Davis George Eric EVP, Chief Legal Officer		BioMarin Pharmaceutical Inc. - BMRN	(6%) 58.59K to 55.25K	0	($1.16M) (23%)	--	$81.29 - $90.00	Show Txns Hide Txns

18-May-22 8:42 PM View:	16-May-22 Grant 0	Burkhart Erin GVP, Chief Accounting Officer		BioMarin Pharmaceutical Inc. - BMRN	100% 0 to 11.13K	0	0	--	--	Show Txns Hide Txns

Buy:	$314.47K	$86.75
Sell:	($4.07M)	$78.33 - $90.00

BioMarin Pharmaceutical Inc. (BMRN)

Last Year

02-Feb-22 -- 01-Feb-23

Company Sentiment

Biotechnology

Drugs

Two Year Chart

02-Feb-21 -- 01-Feb-23

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades